Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent InhibitorsGiuseppe Campiani, Antje Prasse, Caterina Cavella et al.|Journal of Medicinal Chemistry|2021Cited by 55
Development of Potent Inhibitors of the <i>Mycobacterium tuberculosis</i> Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside MacrophagesMarco Paolino, Simone Brogi, Diego Sbardella et al.|ChemMedChem|2018Cited by 48
Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological EvaluationA. Prasanth Saraswati, Giuseppe Campiani, Nicola Relitti et al.|ACS Medicinal Chemistry Letters|2020Cited by 44
Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigationNicola Relitti, Giuseppe Campiani, A. Prasanth Saraswati et al.|European Journal of Medicinal Chemistry|2020Cited by 43
Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viabilityStefano Federico, Giuseppe Campiani, Tuhina Khan et al.|European Journal of Medicinal Chemistry|2022Cited by 30